Medtronic Buys Mazor Robotics For $1.3Bn
Executive Summary
Medtronic is straightening up as a market leader in spinal surgery after agreeing to buy the shares of Mazor Robotics that it does not already own. The $1.3bn deal builds on an existing agreement between the companies formed in May 2016 and strengthens Medtronic as the front runner in the spine robotics field.
You may also be interested in...
LSX 2020: Medtronic, J&J And Olympus Map Their M&A Outlook
At the LSX World Congress in London, leaders from Medtronic, Johnson & Johnson and Olympus discussed the evolving medtech mergers and acquisitions landscape, the big opportunity in robotic surgery and the impacts on innovation of the forthcoming EU Medical Device Regulation.
M&A Analysis: 2019 Promises Buoyant Year For M&A
After a record year for medtech M&A deal-making in 2018, Medtech Insight investigates how activity may unfold in the coming year and some of the biggest trends that could hit the industry.
Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2018
Third quarter device financing totaled $2.6 billion, a 24% decrease from the $3.4 billion brought in during Q2. The change partially stems from a sharp decline in debt financing. During the third quarter, debt raises brought in $258 million, just 10% of the Q3 total, while in the previous quarter, aggregate debt (at $947 million) represented 28% of the financing total.